000 01209 a2200325 4500
005 20250515004457.0
264 0 _c20060228
008 200602s 0 0 eng d
022 _a1083-7159
024 7 _a10.1634/theoncologist.10-90001-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBell, Richard
245 0 0 _aEfficacy of ibandronate in metastatic bone disease: review of clinical data.
_h[electronic resource]
260 _bThe oncologist
_c2005
300 _a8-13 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aIbandronic Acid
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aTreatment Outcome
773 0 _tThe oncologist
_gvol. 10 Suppl 1
_gp. 8-13
856 4 0 _uhttps://doi.org/10.1634/theoncologist.10-90001-8
_zAvailable from publisher's website
999 _c15890508
_d15890508